Hiroshi Maruoka

1.3k total citations
92 papers, 816 citations indexed

About

Hiroshi Maruoka is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, Hiroshi Maruoka has authored 92 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Organic Chemistry, 13 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Hiroshi Maruoka's work include Synthesis and Biological Evaluation (19 papers), Synthesis and biological activity (16 papers) and Synthesis of heterocyclic compounds (16 papers). Hiroshi Maruoka is often cited by papers focused on Synthesis and Biological Evaluation (19 papers), Synthesis and biological activity (16 papers) and Synthesis of heterocyclic compounds (16 papers). Hiroshi Maruoka collaborates with scholars based in Japan, United States and France. Hiroshi Maruoka's co-authors include Kenji Yamagata, Y. TOMIOKA, Motoyoshi Yamazaki, Tsuyoshi Muto, Toshihiro Fujioka, Yoshiaki Tomimori, Yoshiaki Fukuda, Kenneth A. Jacobson, Stefano Costanzi and Fumio Miake and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Hiroshi Maruoka

88 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Maruoka Japan 16 393 205 106 82 56 92 816
Charles Blais Canada 18 129 0.3× 216 1.1× 136 1.3× 29 0.4× 47 0.8× 27 1.1k
Maria Candida Cesta Italy 15 199 0.5× 286 1.4× 161 1.5× 20 0.2× 26 0.5× 35 751
Osamu Asano Japan 12 152 0.4× 215 1.0× 75 0.7× 127 1.5× 86 1.5× 36 652
Ruth A. Henderson United States 12 213 0.5× 329 1.6× 262 2.5× 15 0.2× 73 1.3× 15 1.4k
Maria Berndtsson Sweden 14 74 0.2× 462 2.3× 41 0.4× 36 0.4× 44 0.8× 19 998
Paresh Thakker United States 15 133 0.3× 310 1.5× 360 3.4× 13 0.2× 63 1.1× 25 918
Esther Y. Chao United States 11 132 0.3× 546 2.7× 39 0.4× 90 1.1× 60 1.1× 15 881
Michael C. Nicastri United States 10 266 0.7× 338 1.6× 66 0.6× 57 0.7× 18 0.3× 14 896
Jeffrey O. Saunders United States 9 192 0.5× 363 1.8× 32 0.3× 89 1.1× 25 0.4× 12 877
Lisa M. Greene Ireland 21 606 1.5× 592 2.9× 52 0.5× 20 0.2× 304 5.4× 35 1.7k

Countries citing papers authored by Hiroshi Maruoka

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Maruoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Maruoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Maruoka more than expected).

Fields of papers citing papers by Hiroshi Maruoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Maruoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Maruoka. The network helps show where Hiroshi Maruoka may publish in the future.

Co-authorship network of co-authors of Hiroshi Maruoka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Maruoka. A scholar is included among the top collaborators of Hiroshi Maruoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Maruoka. Hiroshi Maruoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruoka, Hiroshi, Shota Hamada, Takashi Okura, et al.. (2024). Statement on medication simplification in long‐term care facilities by the Japanese Society of Geriatric Pharmacy: English translation of the Japanese article. Geriatrics and gerontology international. 25(1). 14–24. 1 indexed citations
2.
Tanaka, Tomohito, et al.. (2021). Pelvic Abscess after Cesarean Section Treated with Laparoscopic Drainage. Case Reports in Obstetrics and Gynecology. 2021. 1–3. 2 indexed citations
3.
Hamada, Shota, Taro Kojima, Yukari Hattori, et al.. (2021). Use of psychotropic drugs and drugs with anticholinergic properties among residents with dementia in intermediate care facilities for older adults in Japan: a cohort study. BMJ Open. 11(4). e045787–e045787. 5 indexed citations
4.
Maruoka, Hiroshi, et al.. (2021). Synthesis and Reaction of Novel Spiro Pyrazol-3-ones Containing Oxirane Moiety. Heterocycles. 102(7). 1354–1354. 1 indexed citations
5.
Hamada, Shota, Taro Kojima, Hiroshi Maruoka, et al.. (2020). Utilization of drugs for the management of cardiovascular diseases at intermediate care facilities for older adults in Japan. Archives of Gerontology and Geriatrics. 88. 104016–104016. 4 indexed citations
6.
Fujiwara, Satoe, Shinichi Terada, Hiroshi Maruoka, et al.. (2019). GPR30 signaling to regulate epithelial-mesenchymal transition and predict survival in ovarian cancer.. Journal of Clinical Oncology. 37(15_suppl). e17041–e17041. 1 indexed citations
7.
Maruoka, Hiroshi, et al.. (2018). Synthesis and DNA Cleavage Activity of Novel Spiro Pyrazol-3-ones Containing Isoxazoline Moiety. Heterocycles. 96(7). 1289–1289. 3 indexed citations
8.
Shibata, Makoto, et al.. (2015). Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 Inactivation. Chemical and Pharmaceutical Bulletin. 63(10). 825–832. 1 indexed citations
9.
Maruoka, Hiroshi, et al.. (2015). Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model. Bioorganic & Medicinal Chemistry. 23(15). 4792–4803. 14 indexed citations
10.
Todoroki, Kenichiro, Sho Nishida, Hiroshi Maruoka, et al.. (2014). Assessment of the Efficacy of Anticancer Drugs by Amino Acid Metabolomics Using Fluorescence Derivatization-HPLC. Analytical Sciences. 30(7). 751–758. 12 indexed citations
11.
Баласубраманиан, Рамачандран, et al.. (2013). AMP-activated protein kinase as regulator of P2Y6 receptor-induced insulin secretion in mouse pancreatic β-cells. Biochemical Pharmacology. 85(7). 991–998. 14 indexed citations
12.
Terakawa, Maki, Tsuyoshi Muto, Hiroshi Maruoka, et al.. (2011). Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients. International Immunopharmacology. 11(10). 1628–1632. 7 indexed citations
13.
Maruoka, Hiroshi, Matthew O. Barrett, Derek A. Franklin, et al.. (2011). Pyrimidine Nucleotides with 4-Alkyloxyimino and Terminal Tetraphosphate δ-Ester Modifications as Selective Agonists of the P2Y4Receptor. Journal of Medicinal Chemistry. 54(12). 4018–4033. 42 indexed citations
14.
Maruoka, Hiroshi, Matthew O. Barrett, Hyojin Ko, et al.. (2010). Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications. Journal of Medicinal Chemistry. 53(11). 4488–4501. 34 indexed citations
15.
Castro, Sonia de, Hiroshi Maruoka, Kunlun Hong, et al.. (2010). Functionalized Congeners of P2Y1 Receptor Antagonists: 2-Alkynyl (N)-Methanocarba 2′-Deoxyadenosine 3′,5′-Bisphosphate Analogues and Conjugation to a Polyamidoamine (PAMAM) Dendrimer Carrier. Bioconjugate Chemistry. 21(7). 1190–1205. 19 indexed citations
16.
Terakawa, Maki, Yoshiaki Tomimori, Tsuyoshi Muto, et al.. (2008). Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis. European Journal of Pharmacology. 601(1-3). 186–191. 25 indexed citations
17.
18.
Maruoka, Hiroshi, et al.. (2006). A case of polymyositis complicated with interstitial pneumonitis and pneumomediastinum. Modern Rheumatology. 16(1). 55–57. 2 indexed citations
19.
Yamagata, Kenji, et al.. (2005). Synthesis of 2‐amino‐4,5‐dihydro‐3‐methanesulfonylfurans (and ‐thiophenes). Journal of Heterocyclic Chemistry. 42(5). 955–958. 2 indexed citations
20.
Maruoka, Hiroshi, Motoyoshi Yamazaki, & Y. TOMIOKA. (2004). Synthesis of dihydrothieno[2,3‐b]pyridines based on titanium(IV) chloride‐mediated michael reactions of 2‐amino‐4,5‐dihydro‐3‐thiophenecarbonitriles with α,β‐unsaturated ketones. Journal of Heterocyclic Chemistry. 41(4). 641–646. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Blais Breakdown of academic impact, for papers by Maria Candida Cesta Breakdown of academic impact, for papers by Osamu Asano Breakdown of academic impact, for papers by Ruth A. Henderson Breakdown of academic impact, for papers by Maria Berndtsson Breakdown of academic impact, for papers by Paresh Thakker Breakdown of academic impact, for papers by Esther Y. Chao Breakdown of academic impact, for papers by Michael C. Nicastri Breakdown of academic impact, for papers by Jeffrey O. Saunders Breakdown of academic impact, for papers by Lisa M. Greene
Rankless by CCL
2026